TherapeuticsMD, Inc. (TXMD)
USD 1.03
(4.06%)
USD 1.03
(4.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.3 Million | 69.96 Million | 86.95 Million | 64.87 Million | 49.64 Million | 16.09 Million |
| Cost of Revenue | - | 1.39 Million | 18.83 Million | 15.97 Million | 6.33 Million | 2.73 Million |
| Gross Profit | 1.3 Million | 68.56 Million | 68.11 Million | 48.89 Million | 43.31 Million | 13.36 Million |
| Operating Expenses | 9.82 Million | 57.9 Million | 207.88 Million | 204.43 Million | 194.51 Million | 143.58 Million |
| Selling, General and Administrative Expenses | 8.9 Million | 57.9 Million | 200.79 Million | 192.96 Million | 174.11 Million | 115.98 Million |
| Research and Development Expenses | - | - | 7.08 Million | 10.43 Million | 19.79 Million | 27.29 Million |
| Other Expenses | 922 Thousand | -117 Thousand | 272 Thousand | 1.04 Million | 612.78 Thousand | 2.28 Million |
| Cost and Expenses | 9.82 Million | 59.3 Million | 226.72 Million | 220.41 Million | 200.85 Million | 146.31 Million |
| Operating Income | -8.52 Million | 20.13 Million | -139.77 Million | -155.54 Million | -151.2 Million | -130.22 Million |
| Interest Expense | - | - | 32.91 Million | 28.58 Million | 17.38 Million | 4.67 Million |
| Income Tax Expense | 43 Thousand | -91.86 Million | 33.18 Million | 29.17 Million | 19.88 Million | 2.28 Million |
| Earnings before Tax | -7.74 Million | 1.07 Million | -172.41 Million | -183.52 Million | -176.14 Million | -132.61 Million |
| Net Income | -10.27 Million | 111.99 Million | -205.6 Million | -212.7 Million | -196.02 Million | -132.61 Million |
| Earnings Per Share Basic | -0.55 | -10.35 | -25.83 | -38.58 | -39.79 | -29.47 |
| Earnings Per Share Diluted | -0.74 | -10.35 | -25.83 | -38.58 | -39.79 | -29.47 |
| Weighted Average Shares Outstanding | 13.88 Million | 9.02 Million | 7.96 Million | 5.51 Million | 4.92 Million | 4.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.44 Million | 9.02 Million | 7.96 Million | 5.51 Million | 4.92 Million | 4.5 Million |
| Gross Margin | 1.00 | 0.98 | 0.78 | 0.75 | 0.87 | 0.83 |
| EBIT Margin | -6.45 | 0.30 | -1.56 | -2.33 | -2.97 | -7.93 |
| Profit Margin | -7.89 | 1.60 | -2.36 | -3.28 | -3.95 | -8.24 |
| EBITDA | -8.4 Million | 11.85 Million | -78.56 Million | -149.47 Million | -156.3 Million | -127.64 Million |
| Earnings Before Tax Margin | -6.55 | 0.29 | -1.61 | -2.40 | -3.05 | -8.09 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 234 Thousand | 313 Thousand | 1.3 Million | 502 Thousand | -53 Thousand | 437 Thousand |
| Cost of Revenue | 180 Thousand | 133 Thousand | 922 Thousand | 637 Thousand | 130 Thousand | 128 Thousand |
| Gross Profit | 54 Thousand | 180 Thousand | 380 Thousand | -135 Thousand | -183 Thousand | 309 Thousand |
| Operating Expenses | 1.23 Million | 1.32 Million | 8.9 Million | 1.47 Million | 1.72 Million | 2.9 Million |
| Selling, General and Administrative Expenses | 1.23 Million | 1.32 Million | - | 1.47 Million | 1.59 Million | 2.78 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.39 Million | 333 Thousand | 922 Thousand | 433 Thousand | 359 Thousand | 103 Thousand |
| Cost and Expenses | 1.41 Million | 1.45 Million | 9.82 Million | 2.11 Million | 1.72 Million | 2.9 Million |
| Operating Income | -1.17 Million | -1.14 Million | -8.52 Million | -1.61 Million | -1.77 Million | -2.47 Million |
| Interest Expense | 5000.00 | - | - | 85 Thousand | 20 Thousand | 45 Thousand |
| Income Tax Expense | 40 Thousand | -75 Thousand | -43 Thousand | -43 Thousand | 2.32 Million | 148 Thousand |
| Earnings before Tax | -1.05 Million | -809 Thousand | -7.74 Million | -1.58 Million | -1.43 Million | -2.41 Million |
| Net Income | -1.09 Million | -734 Thousand | -10.27 Million | -883 Thousand | -3.37 Million | -2.41 Million |
| Earnings Per Share Basic | -0.09 | -0.06 | - | -0.08 | -0.32 | -0.24 |
| Earnings Per Share Diluted | -0.09 | -0.06 | - | -0.08 | -0.32 | -0.24 |
| Weighted Average Shares Outstanding | 11.53 Million | 11.53 Million | 10.44 Million | 11.53 Million | 10.7 Million | 10.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.53 Million | 11.53 Million | 10.44 Million | 11.53 Million | 10.7 Million | 10.21 Million |
| Gross Margin | 0.23 | 0.58 | 0.29 | -0.27 | 3.45 | 0.71 |
| EBIT Margin | -4.27 | -3.22 | - | -1.94 | 24.23 | -5.13 |
| Profit Margin | -4.66 | -2.35 | -7.89 | -1.76 | 63.74 | -5.52 |
| EBITDA | -999 Thousand | -1 Million | - | -974 Thousand | -1.28 Million | -2.24 Million |
| Earnings Before Tax Margin | -5.04 | -3.65 | -6.55 | -3.21 | 33.45 | -5.66 |
JCKH
6210
SHAREINDIA
XPL
4109
6659